Two Sigma Advisers’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25M | Sell |
1,564,200
-175,600
| -10% | -$2.81M | 0.05% | 293 |
|
|
2025
Q1 | $33.8M | Sell |
1,739,800
-71,300
| -4% | -$1.39M | 0.08% | 236 |
|
|
2024
Q4 | $39.9M | Buy |
1,811,100
+470,000
| +35% | +$10.4M | 0.09% | 196 |
|
|
2024
Q3 | $22.6M | Buy |
1,341,100
+120,000
| +10% | +$2.02M | 0.05% | 297 |
|
|
2024
Q2 | $14.6M | Buy |
1,221,100
+52,200
| +4% | +$624K | 0.03% | 426 |
|
|
2024
Q1 | $13M | Sell |
1,168,900
-10,000
| -0.8% | -$111K | 0.03% | 450 |
|
|
2023
Q4 | $10.2M | Buy |
1,178,900
+827,700
| +236% | +$7.17M | 0.02% | 521 |
|
|
2023
Q3 | $2.69M | Buy |
351,200
+271,300
| +340% | +$2.08M | 0.01% | 1041 |
|
|
2023
Q2 | $575K | Buy |
+79,900
| New | +$575K | ﹤0.01% | 1765 |
|